Skip to main content
Premium Trial:

Request an Annual Quote

Teranode, Science Commons to Build Neurology Repository for Semantic Web

NEW YORK, Dec. 13 (GenomeWeb News) - Teranode and Science Commons, a project of the non-profit corporation Creative Commons, plan to build a neurology repository for the Semantic Web, the groups said yesterday.

 

The project, NeuroCommons.org, will be a freely accessible neurology commons of tools and pathway data designed to be used by public and private researchers, the partners said.

 

Terms of the alliance call for Science Commons to use Teranode's XDA platform as the infrastructure for NeuroCommons.org. All content will be available in Resource Description Framework, which would enable participating foundations to search and access a shared repository of data and research.

 

The collaboration may "lower unintended legal and technical barriers to research, facilitate communication and materials usage between scientists, and increase innovation opportunities for accelerated research of new therapies," John Wilbanks, executive director for Science Commons, said in a statement.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.